Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 17%
Hold 50%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services has demonstrated a strong financial performance, with its acute care segment's same-store adjusted EBITDA margin expanding by 190 basis points to 15.8%. The behavioral health segment has also shown robust growth, with same-store revenue increasing by 9.3%, while overall patient volumes and revenue per adjusted admission reflect positive trends. The company's strategic initiatives pending CMS approval could yield an estimated benefit of $75-80 million, further bolstering its favorable outlook for sustained revenue growth and margin improvement in 2026.

Bears say

Universal Health Services is facing a negative outlook primarily due to projected earnings that are approximately 5% below earlier estimates for fiscal year 2026, resulting from anticipated volume and margin challenges. The company’s behavioral volumes are expected to trend at only 2% for 2026, following a downward adjustment in its long-term growth outlook, which could significantly impact EBITDA as the contribution from its DPP segment is projected to decline starting in 2028. Additional risks include high market concentration in Las Vegas, potential regulatory changes, and tightening labor supply that could further weaken productivity and margins in urban areas.

UHS has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 17% recommend Buy, 50% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 12 analysts, UHS has a Buy consensus rating as of Mar 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $230.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $230.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.